Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
The American Journal of the Medical Sciences|September 19, 2012
A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myelomaJingsong He, Li Yang, Xiaojian Meng, et al.
Chinese Medical Journal|November 6, 2024
Predictive value of pre-treatment circulating tumor DNA genomic landscape in patients with relapsed/refractory multiple myeloma undergoing anti-BCMA CAR-T therapy: Insights from tumor cells and T cellsRongrong Chen, Chunxiang Jin, Kai Liu, et al.
Cancer Immunology Research|July 22, 2021
CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy StudyGuoqing Wei, Yanlei Zhang, Houli Zhao, et al.
Bone Marrow Transplantation|March 31, 2023
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapyShan Fu, Qiqi Zhang, Ruirui Jing, et al.
Infection and Drug Resistance|December 5, 2022
Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation RecipientsWeihao Chen, Yanmin Zhao, Yi Luo, et al.
Cell Transplantation|January 6, 2024
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline MutationsTingting Yang, Rongrong Chen, Mingming Zhang, et al.
Experimental Hematology & Oncology|January 3, 2025
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemiaTingting Yang, Yetian Dong, Mingming Zhang, et al.
HLA|May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical StudyHaiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Leukemia|July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemiaMingming Zhang, Lianxuan Liu, Shan Fu, et al.
Frontiers in Oncology|August 23, 2021
Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin LymphomaRuimin Hong, Elaine Tan Su Yin, Linqin Wang, et al.
Pageof 18